These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7694212)

  • 1. Hepatic perfusion index: a new and useful factor in predicting survival among patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Kao CH; Hsu CY; Liao SQ; Yeh SH
    Nucl Med Commun; 1993 Oct; 14(10):878-82. PubMed ID: 7694212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Yeh SH
    Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.
    Aoyagi Y; Isokawa O; Suda T; Watanabe M; Suzuki Y; Asakura H
    Cancer; 1998 Nov; 83(10):2076-82. PubMed ID: 9827711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
    Yamashita F; Tanaka M; Satomura S; Tanikawa K
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):627-33. PubMed ID: 8590157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of mrp gene in primary hepatocellular carcinoma.
    Wang BL; Chen XP; Zhai SP; Chen DF
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):397-403. PubMed ID: 14599947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
    Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
    Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
    Yano Y; Yamashita F; Kuwaki K; Fukumori K; Kato O; Yamamoto H; Ando E; Tanaka M; Sata M
    Liver Int; 2006 Sep; 26(7):789-95. PubMed ID: 16911460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver resection after transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma and curative effect analysis].
    Fan J; Yu Y; Wu Z
    Zhonghua Wai Ke Za Zhi; 1997 Dec; 35(12):710-2. PubMed ID: 10677986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective assessment of the hepatic perfusion index in patients with colorectal cancer.
    Warren HW; Gallagher H; Hemingway DM; Angerson WJ; Bessent RG; Wotherspoon H; McArdle CS; Cooke TG
    Br J Surg; 1998 Dec; 85(12):1708-12. PubMed ID: 9876080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
    O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
    Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.